DEPRESSIVE DISORDER ADVISOR

Depression Advisor

Features

Treatments for Resynchronization in Sleep and Depression

Researchers found data that show adverse lifestyle factors increase the risk for depression.
Sensible Strategies to Overcome Barriers to Depression Treatment

Researcher data showed that the boundaries to successful treatment in depression in patients who are minorities are varied, but that there are certain predisposing factors such as adverse childhood events and genetics.
Health Technology Designed to Engage With Major Depressive Disorders

Researchers discovered that self-management strategies through the use of mobile applications improves adherence to medications with reminders and messages of support.
Social Cognitive Deficits in Major Depressive Disorders

A range of studies show that connections among social identification, perception, and interpretation of social situations affect quality of life in patients with major depressive disorders.
Brain Insulin Resistance and MDD

Researchers believe that data show stress impairs the hypothalamus-pituitary-adrenal axis and sympathetic nervous system, causing inflammation that is the link between type 2 diabetes mellitus and depression.

News

Depression Treatment Response in Relation to Body Mass Index

By

Psychiatry Advisor Contributing Writer

July 19, 2019

Memory Deficits Linked to Functional Disconnectivity in Major Depressive Disorder

By

Psychiatry Advisor Contributing Writer

July 19, 2019

Lower-Range Doses of Antidepressants Most Effective for Major Depression

By

Psychiatry Advisor Contributing Writer

July 19, 2019

Childhood Adversity May Lead to Inflammation in Adult Depression

By

Psychiatry Advisor Contributing Writer

July 12, 2019

Journal Articles

Keren H, O’Callaghan G, Vidal-Ribas P, et al. Reward processing in depression: a conceptual and meta-analytic review across fMRI and EEG studies
[published online June 20, 2018]. Am J Psychiatry. doi: 10.1176/appi.ajp.2018.17101124

Emsley R, Ahokas A, Suarez A, et al. Efficacy of tianeptine 25-50 mg in elderly patients with recurrent major depressive disorder: an 8-week placebo- and escitalopram-controlled study.
J Clin Psychiatry. 2018; 79(4)

Jovanova OS, Nedeljkovic I, Derek S, et al. DNA methylation signatures of depressive symptoms in middle-aged and elderly persons
[published online July 11, 2018]. JAMA Psychiatry. doi: 10.1001/jamapsychiatry.2018.1725

Burkhouse KL, Gorka SM, Klumpp H, et al. Neural responsiveness to reward as an index of depressive symptom change following cognitive-behavioral therapy and SSRI treatment.
J Clin Psychiatry. 2018; 79(4).

Hsu MC, Tung CY, Chen HE. Omega-3 polyunsaturated fatty acid supplementation in prevention and treatment of maternal depression: Putative mechanism and recommendation.
J Affect Disord. 2018; ;238:47-61.

Patient Education Materials

U.S. Department of Health and Human Services. Depression: What You Need to Know.

U.S. Department of Health and Human Services. Obsessive-Compulsive Disorder.

U.S. Department of Health and Human Services. Generalized Anxiety Disorder: When Worry Gets Out of Control.

U.S. Department of Health and Human Services, National Institutes of Health. Panic Disorder: When Fear Overwhelms.

Related Links

Next post in Depression Advisor

Over time, the degeneration of synaptic connections causes neuronal injury and death. This widespread neuronal death eventually causes atrophy of key brain regions, namely the hippocampus and temporal lobe, although widespread cerebral atrophy is seen in advanced cases of the disease.

Memory Deficits Linked to Functional Disconnectivity in Major Depressive Disorder